← back to search

Kyle Kai‐How Farh

Illumina (United States) · US
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Genomics and Phylogenetic Studies, Primate Behavior and Ecology, Genomics and Rare Diseases, and Genetic Associations and Epidemiology.
h-index
25
citations
22,382
works
66
NIH funding
primary concept
Biology
email

Recent publications

Predicting expression-altering promoter mutations with deep learning
Science 2025cited by 38position: lastdoi
Estimation and mapping of the missing heritability of human phenotypes
Nature 2025cited by 18position: middledoi
Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
Science 2024cited by 41position: middledoi
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression
Nature Cell Biology 2024cited by 18position: middledoi
A global catalog of whole-genome diversity from 233 primate species
Science 2023cited by 207position: middledoi
The landscape of tolerated genetic variation in humans and primates
Science 2023cited by 173position: lastdoi
Phylogenomic analyses provide insights into primate evolution
Science 2023cited by 165position: middledoi
Identification of constrained sequence elements across 239 primate genomes
Nature 2023cited by 107position: lastdoi
Rare penetrant mutations confer severe risk of common diseases
Science 2023cited by 72position: lastdoi
Genome-wide coancestry reveals details of ancient and recent male-driven reticulation in baboons
Science 2023cited by 44position: middledoi
Rare penetrant mutations confer severe risk of common diseases
medRxiv 2023cited by 5position: lastdoi
Chromatin and gene-regulatory dynamics of the developing human cerebral cortex at single-cell resolution
Cell 2021cited by 518position: middledoi
PICS2: next-generation fine mapping via probabilistic identification of causal SNPs
Bioinformatics 2021cited by 45position: lastdoi
Variation in predicted COVID‐19 risk among lemurs and lorises
American Journal of Primatology 2021cited by 13position: middledoi
The DNA methylation landscape of advanced prostate cancer
Nature Genetics 2020cited by 349position: middledoi
Predicting Splicing from Primary Sequence with Deep Learning
Cell 2019cited by 2,841position: lastdoi
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
Cell 2018cited by 742position: middledoi
Fine-mapping inflammatory bowel disease loci to single-variant resolution
Nature 2017cited by 640position: middledoi
Discovery of stimulation-responsive immune enhancers with CRISPR activation
Nature 2017cited by 318position: middledoi
Partitioning heritability by functional annotation using genome-wide association summary statistics
Nature Genetics 2015cited by 3,031position: middledoi
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Nature 2014cited by 2,136position: firstdoi
Genome-wide identification and characterization of functional neuronal activity–dependent enhancers
Nature Neuroscience 2014cited by 286position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jeremy F. McRae · Illumina (United States)4 papers (2019–2025)Pierrick Wainschtein · University of Queensland3 papers (2023–2025)Petko Fiziev · Illumina (United States)3 papers (2023–2025)Hong Gao · Harbin Medical University3 papers (2019–2023) · 2 papers (2023–2023)Amit V. Khera · Institut universitaire de cardiologie et de pneumologie de Québec2 papers (2023–2023)Jacqueline S. Dron · Massachusetts Institute of Technology2 papers (2023–2023)Jacob C. Ulirsch · Illumina (United States)2 papers (2023–2023)Yair Field · Illumina (United States)2 papers (2023–2023)Alexander Marson · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2014–2021)Yanshen Yang · Xi'an Jiaotong University2 papers (2023–2023) · 2 papers (2023–2023)François Aguet · Biopredic (France)2 papers (2023–2023)Tomàs Marquès‐Bonet · Institució Catalana de Recerca i Estudis Avançats2 papers (2023–2023)Dylan Cable · Broad Institute2 papers (2023–2023)Ahmed A. Metwally · Google (United States)2 papers (2023–2023)Jeffrey Rogers · Baylor College of Medicine2 papers (2023–2023)Anne O’Donnell‐Luria · Broad Institute2 papers (2023–2023)Mark J. Daly · University of Helsinki2 papers (2014–2015) · 2 papers (2023–2023)